Elēkrŏn Ventures invests in opportunities that create impact in any potential sector without limitations on a particular investment stage. With a higher interest in early-stage investments, we identify ventures where we can add true value which in turn mitigates the risk and optimizes the possibility of success given our experienced team and network.

Elēkrŏn Ventures

SeedToB Capital primarily focuses on artificial intelligence initiatives within healthcare. Most applications of AI in healthcare have results in pilot and early adaptor settings but don’t maximize their full potential of value despite huge investments. seedToB’s unique approach is to help entrepreneurs navigate this complex space towards most efficient path to Series B. It is led by serial entrepreneurs who in their last startup founded Jvion and grew it to be the Nation’s largest clinical AI company which was sold at nine figure valuation in a all cash transaction.

SeedToB Capital

Alumni Ventures Group provides high-quality, diversified venture portfolios to individual investors who previously haven't had access to VC. It helps accredited alums from top entrepreneurial schools invest together in the ventures of fellow alums. The firm backs companies with an alumni connection and an institutional lead investor with expertise in the space. AVG also offers focused funds that allow any accredited investor access to a venture portfolio, diversified by type, sector, stage, and geography. Beth Obermiller, Michael Madden, and Mike Collins co-founded the firm in Manchester, New Hampshire in 2013.

Alumni Ventures

Surface Ventures is a seed and pre-seed venture capital firm focused on partnering with B2B software companies.

Surface Ventures

TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders. Led by a seasoned team of venture investors, ex-founders, and investment management executives, we invest our capital, time, and network into highly defensible, fast-growing companies with the potential to solve the world’s largest problems. Our strategy is grounded on writing high conviction checks at Pre-Seed and Seed with healthy follow-on reserves through Series A; demonstrating deep value to enable increased ownership over time. Our experienced team is headquartered in New York City and London, but we are excited to meet founders from around the world with a strong preference for diverse founding teams. At its core, we believe that diversity is not only good for business, but great for financial returns.

The Venture Collective

Gron Ventures is a venture capital firm that invests in the cannabis, e-commerce, food-tech, consumer products, and services sectors.

Gron Ventures

JAM Fund operates as a venture capital firm investing in visionary founders disrupting large spaces. It is Tinder Founder Justin Mateen's venture capital firm.

JAM Fund

Thiel Capital is an investment firm founded by Peter Thiel. Located in Los Angeles, Thiel Capital provides strategic and operational support for Peter’s many investment initiatives and entrepreneurial endeavors. Related organizations include Founders Fund, Mithril, Valar Ventures, and The Thiel Foundation.

Thiel Capital

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital to date.  The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Gaingels

Anti Fund is a quickly growing venture capital fund founded by Geoffrey Woo and Jake Paul.

Anti Fund

One Mind Accelerator provides founders with the network, knowledge, and funding they need to establish strong, distinctive, and moral businesses that bring innovations to market more quickly and have a bigger impact on those who are dealing with mental illness.

One Mind Accelerator

What do Peter Thiel, Kevin O’Leary, Tim Ferris, Sam Harris, Michael Pollan, Sting, and Tony Robbins all have in common? They are either advocates for or directly investing in psychedelic medicine and research.  The past decade has ushered in a psychedelic renaissance, inspiring a massive push for research, decriminalization, and legalization of these powerful substances. There has been a radical shift in discussions of consciousness expansion, which has broken into the mainstream. With newfound, burgeoning support ranging from academia to medicine, government to business, there’s an extraordinary opportunity to tap into the commercial and social potential of this nascent space.  Mystic Ventures believes the world would be much better if more people experienced the healing power of psychedelics. Mystic cares about mental health and human conditions. The fund’s goal is to draw on my experience as an entrepreneur and investor, backing pre-seed and seed-stage startups creating high-quality psychedelic experiences and treatments. I am starting Mystic to support founders who realize the healing power of psychedelics to elevate humanity’s consciousness. I will harness my broad network and abundance of resources to ensure the success of these ventures. Given my reach throughout the investing world and social media, as well as a growing network within the psychedelic space, I am confident that we will have outstanding deal flow and access to any emerging opportunities. We will draw on a wide range of industry experts, from medical professionals to academics, to validate startup theses, but the focus will be on investing in world-class, dynamic founders.  Given how early this industry is, it’s difficult to pinpoint precisely how big the market opportunity is— but considering the large, ever-expanding applications of psychedelic medicines and therapies, the potential is nothing short of mind-boggling. The global market for drugs used in mental disorders was $70.1 billion in 2012. Just the antidepressant drug market was valued at $13.69b in 2015. More broadly, in 2019, mental health spending topped $225 Billion in the US alone. Two publicly traded psychedelic companies, both founded in the past five years, Compass Pathways and MindMed (which we were offered pre-IPO access to), have market capitalizations over $1 billion, and many more have nine-figure valuations. In contrast, the global legal marijuana market was valued at $17.7 billion in 2019. Thus, it’s hard to overstate how large and how quickly this space could grow. The priority is getting this fund to market as soon as possible, which is why we chose a Rolling Fund. Whenever possible, I will spin up SPVs for LPs that would like larger exposure to deals or when it's deemed appropriate to do follow-on investments.

Mystic Ventures

Heading Health

Heading Health is a technology-enabled mental health platform improving access to affordable care. It delivers personalized treatment solutions that leverage evidence-based therapeutics and technologies such as Spravato, transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine.

<div>Heading Health is a technology-based mental health platform.&nbsp;</div>

New technologies are opening up mental health services to previously overbooked and underserved populations.

Mental Health Tech

Heading Health Funded $4.5M for a Revolutionize Extension Mental Health Care

<div>
 
 Heading Health is a technology-based mental health platform.&nbsp;
 
 
 
 
 Through teletherapy, telepsychiatry, and interventional treatments such as Spravato, transcranial magnetic stimulation, and intramuscular ketamine, Heading provides personalized treatment solutions that leverage a comprehensive toolkit to address longstanding and chronic mental health disorders such as treatment-resistant depression, anxiety, and PTSD.&nbsp;
 
 
 
 
 Heading combines psychotherapy, psychiatry, nutrition, and interventional modalities &ndash; and had plans for psychedelic treatments in the works &ndash; to offer outcome-focused treatments.
 
 
 
 
 The company is an insurance-based mental healthcare provider, with most patients paying for care in part or fully through insurance. For those without an insurance plan or those who opt not to use insurance, a payment plan is set up depending on the services required.&nbsp;
 
 
 
 
 Key customers and partnerships
 
 
 Heading Health partners with major insurance planners such as UnitedHealthcare, Atena, Medicare, and Humana.
 
 
 
 
 Funding and financials
 
 
 Heading Health&rsquo;s latest round of funding was in June 2023, when it raised USD 4.5 million in a series A round led by JAM Fund and Gron Ventures.
 
</div>

<div>
 
 Boulder Care is a telepsychiatry platform that connects patients who are opioid-addicted users to addiction specialists, care coordinators, and peer coaches. Patients can get personalized plans via video and text messaging and the app is intended to be used in conjunction with prescription medicines and lab tests.
 
 
 Funding and financials
 
 
 In June 2022, the company raised USD 36 million in a Series B funding round. The funds were earmarked to triple the size of the company’s medical care team, expand its geographical footprint, and increase its value-based care treatment options through partnerships with health plans.
 
</div>

Boulder Care

<div>
 
 7 Cups provides an emotional-support platform with a network of volunteer listeners. Users can anonymously access either one-on-one chats or group chats 24/7, free of charge for issues such as depression, anxiety, relationships and those related to the LGBTQ+ community. It also teaches users skills such as meditation to improve their lives. If users want additional support, the company also provides access to an online therapy platform with a network of 180 licensed therapists for a subscription plan of USD 150 per month. 7 Cups is available for users above 13 years of age (users between 13 and 17 years old engage with listeners who are specifically trained in teenage interactions).
 
 
 Volunteer peer listeners get free training and support as well as flexible scheduling. Once a user requests a chat, it will be directed to available listeners and if the user requests a specific listener, he will be connected as soon as the listener accepts the demand. The service is anonymous and the listener has no access to the details of the user unless the information is disclosed to the listener by the user in their conversations. As of January 2022, 7 Cups has facilitated more than 51 million conversations, served 25 million individuals, and had 300,000 trained listeners. The listeners serve in 180 countries in 140 languages.
 
</div>

7 Cups

wayForward provides technology-supported behavioral health and emotional wellness services for employers planning to make services available to their employees. It uses a screening procedure designed by neuropsychologists to triage and help employee members get clinically relevant mental healthcare. The company provides a self-guided app, text-based coaching, video visits, telepsychiatry, and if required, in-person visits or an on-site counselor. wayForward leverages its evidence-based approach and artificial intelligence in delivering its services and claims that it has been able to reduce anxiety symptoms by 48% and depression symptoms by 59%.The company raised USD 2 million in a seed round in June 2020, which brought total funding to USD 4.5 million. DarioHealth, a chronic disease management platform based in Israel, signed a definitive agreement to acquire 100% of wayForward in May 2021 for a total consideration of USD 30 million. As of May 2021, the wayForward had approximately 20,000 members and was available in North America, Australia, and Europe.

wayForward

Coa is a mental health company that conducts online classes led by licensed therapists for mental health users. The classes focus on conditions such as stress, anxiety, confidence and relationships. The company raised USD 3 million in a seed round in October 2020 from investors led by Crosslink Capital.

<div>
 
 Meru Health is an online platform that connects patients experiencing stress, depression, anxiety, burnout, and other mental health issues to licensed therapists. The company was founded by Kristian Ranta in 2016 after his older brother died from suicide after battling depression. The platform offers a 12-week program and personalized text-based coaching services and virtual workshops. Meru also provides access to progress reports and anonymous peer support groups as well as sleep, nutrition, and mindfulness advice on top of vital tracking information—such as heart rate data.
 
 
 The company reported a 10x YoY growth in its customer base in 2020 and plans to serve 10 million users by 2027. The company also achieved 8x YoY growth in revenue in 2020 amid an increase in demand in mental health services brought about by the Covid-19 pandemic.
 
 
 Key customers and partnerships
 
 
 In September 2022, Meru Health and clinical trial platform Curebase 
 <a href="https://sp-edge.com/updates/13230">
 announced a partnership
 </a>
 to carry out a three-year clinical trial to measure the effectiveness of Meru Health’s 12-week digital depression treatment targeting primary care patients. The study was funded by the National Institutes of Health’s Small Business Innovation Research program. 
 
 
 
 
 
 Fundings and financials
 
 
 In May 2022, the company secured a USD 2 million grant from the National Institute of Mental Health to measure the effectiveness of its 12-week program for treating primary care patients. The study will follow 300 patients across the US with symptoms of major depression for a period of three years.
 
</div>

Meru Health

Online peer-to-peer platform and support system that connects mental health communities.

Mobile-based apps and FDA-approved software that incorporate evidenced-based cognitive behavioral therapy to prevent, treat, or manage mental and behavioral conditions in conjunction with or as a replacement for traditional medication.

Products for behavioral health and mental health tracking, measurement-based care, and real-time remote monitoring of patients.

Subscription or membership-based platforms and apps to connect therapists, psychiatrists or behavioral health coaches with patients.

Offers virtual offerings for mental health consultations

Mental healthcare services offer personalized care tailored to a user's needs and treatment progression

There are mental health providers offering services specifically to help LGBTQ+ or BIPOC individuals

Several mental health technology providers offer therapy services rendered by AI/ML technology

Heading Health

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless